The Johns Hopkins Bloomberg School of Public Health reports that mpox clade I is more likely to cause severe illness and death than clade II, with reported fatality rates for clade I ranging from 1% to 10% and for clade II ranging from less than 1% to 4%.
October 17, 2025
high
epidemiological
Comparative severity and reported fatality ranges for two genetic clades of the mpox virus as reported by a public health institution.
In 2024, a joint investigation by KFF Health News, the Johns Hopkins Bloomberg School of Public Health, and Shatterproof found that nationwide more than $61 million in opioid settlement funds were spent on law enforcement-related efforts.
December 31, 2024
high
temporal
Findings from a 2024 investigation of how opioid settlement money was spent by states and localities.
In 2024, states and localities spent or committed nearly $2.7 billion in opioid settlement funds, according to public records compiled by the investigation.
December 31, 2024
high
temporal
Aggregate amount of opioid settlement spending or commitments documented in 2024 public records.
In 2024, approximately 20% of opioid settlement funds were untrackable through public records, based on the investigation's compilation of expenditures.
December 31, 2024
high
temporal
Proportion of settlement funds that could not be traced via public records in the 2024 investigation.
KFF Health News, the Johns Hopkins Bloomberg School of Public Health, and Shatterproof conducted a yearlong documentation effort in 2024 and compiled a database of more than 10,500 recorded ways opioid settlement funds were used or not used.
December 31, 2024
high
temporal
A 2024 collaborative data collection effort to track jurisdictional spending of opioid settlement money.